Syra Health Corp. (SYRA)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
May 13, 2025, 1:48 PM EDT
Syra Health Revenue
Syra Health had revenue of $1.86M in the quarter ending March 31, 2025, with 6.02% growth. This brings the company's revenue in the last twelve months to $8.09M, up 33.04% year-over-year. In the year 2024, Syra Health had annual revenue of $7.98M with 44.73% growth.
Revenue (ttm)
8.09M
Revenue Growth
+33.04%
P/S Ratio
0.19
Revenue / Employee
106.41K
Employees
94
Market Cap
1.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.98M | 2.47M | 44.73% |
Dec 31, 2023 | 5.52M | -102.56K | -1.83% |
Dec 31, 2022 | 5.62M | 4.21M | 298.43% |
Dec 31, 2021 | 1.41M | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Syra Health News
- 2 days ago - Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY - PRNewsWire
- 12 days ago - Syra Health To Discuss First Quarter 2025 Financial Results - PRNewsWire
- 6 weeks ago - Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market - PRNewsWire
- 2 months ago - Syra Health Secures $660,000 Population Health Contract Extension - PRNewsWire
- 2 months ago - Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY - PRNewsWire
- 2 months ago - Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire